TipRanks
Go Ultimate75% OFF

Emily Field Profile - Barclays Analyst

74 Followers

Emily Field's Stock Coverage

CYTK
Cytokinetics
Nov 05, 2026BUYReiterated$110.0010Ratings38%+15.01%
PFE
Pfizer
Nov 03, 2026SELLReiterated$25.007Ratings17%-12.33%
LLY
Eli Lilly & Co
Oct 29, 2026BUYReiterated$1,400.0036Ratings100%+28.30%
BMY
Bristol-Myers Squibb
Oct 29, 2026BUYReiterated$75.0010Ratings89%+7.66%
MRK
Merck & Company
Oct 28, 2026BUYReiterated$180.0016Ratings100%+21.98%
GILD
Gilead Sciences
Oct 28, 2026HOLDReiterated$145.006Ratings――
BIIB
Biogen
Oct 28, 2026HOLDReiterated$230.008Ratings――
AMGN
Amgen
Oct 26, 2026HOLDReiterated$400.0011Ratings――
ABBV
AbbVie
Oct 21, 2026BUYReiterated$325.0012Ratings100%+24.03%
SNY
Sanofi
Jan 06, 2026HOLDDowngraded―1Ratings――

Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.

Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Emily Field activity FAQ

What is the performance of Emily Field's recommendations?
The percentage of profitable recommendations made by Emily Field is 45.88%, and the average return per transaction is 2.20%.
What stocks does Emily Field cover?
Emily Field mostly covers Cytokinetics, Pfizer, Bristol-Myers Squibb stocks.
What was Emily Field's most profitable rating?
Emily Field’s most profitable rating was a buy on Cytokinetics stock on May 07, 2025. The return on the trade was 124.80%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here